
Alnamik 250mg Injection
Marketer
Rishab Healthcare pvt. Ltd.
Salt Composition
Amikacin (250mg)
Overview Alnamik 250mg Injection
Cefamandole 250mg injection combats a broad spectrum of bacterial infections, including those affecting the urinary tract, musculoskeletal system, respiratory system (such as pneumonia), central nervous system, and bloodstream. Prophylactic use in hospitalized patients is also indicated. Its mechanism involves inhibiting bacterial growth. Administered intravenously (IV infusion) or intramuscularly by a healthcare professional only, it requires strict adherence to the prescribed dosage schedule. Complete the entire course of treatment, even with symptom improvement, to prevent relapse. Common adverse effects include injection site reactions and elevated blood urea nitrogen (BUN). Persistent side effects or lack of therapeutic response warrant immediate medical consultation. High-dose therapy may rarely cause vertigo, nephrotoxicity, and ototoxicity. Consequently, rigorous adherence to physician instructions is crucial, including regular monitoring of renal function, auditory acuity, and urinalysis. Pregnancy contraindicates its use; inform your doctor of pregnancy, pregnancy planning, or breastfeeding.
Primary Ingredients of Alnamik 250mg Injection
No text was provided to rewrite.
Uses of Alnamik 250mg Injection
Infections caused by bacteria
Major Benefits of Alnamik 250mg Injection:
Administering this medication will be handled by your physician or their qualified staff; self-medication is strictly prohibited.
Common Side effects of Alnamik 250mg Injection:
- Increased blood urea
- Injection site reactions (pain, swelling, redness)
How to use Alnamik 250mg Injection:
This medication will be administered by your physician or their designated nurse. Self-medication is strictly prohibited.
How Alnamik 250mg Injection works:
Alnamik 250mg injection is a bacterial growth inhibitor, acting as an antibiotic by disrupting the production of proteins crucial for bacterial survival.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse interactions between Alnamik 250mg Injection and alcohol consumption.
PregnancyCONSULT YOUR DOCTOR
Administering Alnamik 250mg Injection during gestation poses a confirmed risk to fetal development and is therefore inadvisable. Exceptions may exist in critical circumstances where a physician deems the potential advantages outweigh the hazards. Physician consultation is essential.
Breast feedingSAFE IF PRESCRIBED
The injectable medication Alnamik, 250mg, presents no known breastfeeding contraindications. Research in humans indicates minimal to negligible transfer of the drug into breast milk, posing no discernible risk to the infant.
DrivingUNSAFE
Administering Alnamik 250mg Injection may cause drowsiness, blurred vision, and dizziness, potentially impairing alertness. Driving should be avoided if these effects are experienced.
KidneyCAUTION
Administering Alnamik 250mg Injection to individuals with impaired renal function requires careful consideration. Dosage modification of Alnamik 250mg Injection might be necessary. Physician consultation is advised.
LiverSAFE IF PRESCRIBED
The use of Alnamik 250mg Injection in individuals with hepatic impairment appears to pose minimal risk. Existing evidence indicates that dosage modification may not be necessary for this patient population. However, physician consultation is recommended.
What if you forget to take Alnamik 250mg Injection :
Omitting a scheduled dose of Alnamik 250mg Injection warrants immediate physician consultation.
Facts to Know About Alnamik 250mg Injection
| Label | Value |
|---|---|
| Chemical Category | Aminoglycoside antibiotics |
| Developing Habits | No. |
| Treatment Category | Antimicrobial Agents |
| Behavioral Class | Aminoglycoside antibiotics |
